ADvantage Therapeutics, Inc.

Biotechnology company · Miami, Florida, United States

ADvantage Therapeutics, Inc. is a biotechnology company headquartered in Miami, Florida, United States. Its earliest recorded incorporation is in 2021. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.2 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $14 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

ADvantage Therapeutics at a glance

Typebiotechnology company
HeadquartersMiami, Florida, United States
Earliest incorporation on record2021
Employees (self-reported, 2025)15
SEC CIK1869338

What does ADvantage Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1.2 million in total (2025). NIH funding came from the National Institute on Aging.

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $13.7 million sold (2025).

Frequently asked questions about ADvantage Therapeutics

Where is ADvantage Therapeutics headquartered?

ADvantage Therapeutics, Inc. is headquartered in Miami, Florida, United States.

What does ADvantage Therapeutics do?

ADvantage Therapeutics, Inc. is a biotechnology company.

When was ADvantage Therapeutics founded?

The earliest incorporation on record for ADvantage Therapeutics, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences